Business Description
Select Medical Holdings Corp
NAICS : 622110
SIC : 8062
ISIN : US81619Q1058
Share Class Description:
FRA:S24: Ordinary SharesTotal Employee Number:
45,300Description
Select Medical Holdings Corp is a U.S. healthcare provider operating long-term acute care and rehabilitation hospitals, inpatient rehabilitation facilities, and outpatient physical therapy clinics. Its critical illness recovery hospitals, branded Select Specialty Hospital, treat patients recovering from severe illness or injury who still require intensive care. Its rehabilitation hospitals, operating under the Select Medical Rehabilitation Hospital and other brands, provide intensive inpatient physical and cognitive rehabilitation. The outpatient rehabilitation segment, largely through Physiotherapy Associates and Select Physical Therapy, delivers physical, occupational, and speech therapy in clinics across the United States. Patients are typically transferred from general acute care hospitals. Select Medical also operates Concentra, which provides occupational health, urgent care, and employer-based medical services. Revenue comes primarily from patient services reimbursed by Medicare, Medicaid, private insurers, and managed care plans, with Concentra also serving employers and workers' compensation programs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.7 | |||||
Debt-to-EBITDA | 5.76 | |||||
Interest Coverage | 2.75 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.66 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EBITDA Growth Rate | 12.5 | |||||
3-Year EPS without NRI Growth Rate | -1.9 | |||||
3-Year FCF Growth Rate | 8 | |||||
3-Year Book Growth Rate | 16 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.79 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.82 | |||||
9-Day RSI | 61.68 | |||||
14-Day RSI | 60.96 | |||||
3-1 Month Momentum % | 0.72 | |||||
6-1 Month Momentum % | 13.93 | |||||
12-1 Month Momentum % | 11.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.15 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.03 | |||||
Days Sales Outstanding | 58.93 | |||||
Days Payable | 12.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.5 | |||||
Dividend Payout Ratio | 0.23 | |||||
3-Year Dividend Growth Rate | -20.6 | |||||
Forward Dividend Yield % | 1.49 | |||||
5-Year Yield-on-Cost % | 1.5 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | 49.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 11.31 | |||||
Operating Margin % | 5.83 | |||||
Net Margin % | 2.42 | |||||
EBITDA Margin % | 9.4 | |||||
FCF Margin % | 2.85 | |||||
OCF Margin % | 7 | |||||
ROE % | 7.82 | |||||
ROA % | 2.3 | |||||
ROIC % | 5.04 | |||||
3-Year ROIIC % | -11.5 | |||||
ROC (Joel Greenblatt) % | 17.17 | |||||
ROCE % | 7.75 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.58 | |||||
Forward PE Ratio | 13.6 | |||||
PE Ratio without NRI | 15.58 | |||||
Shiller PE Ratio | 9.18 | |||||
Price-to-Owner-Earnings | 18.68 | |||||
PS Ratio | 0.36 | |||||
PB Ratio | 1.17 | |||||
Price-to-Free-Cash-Flow | 13.18 | |||||
Price-to-Operating-Cash-Flow | 5.17 | |||||
EV-to-EBIT | 14.26 | |||||
EV-to-Forward-EBIT | 12.81 | |||||
EV-to-EBITDA | 10.33 | |||||
EV-to-Forward-EBITDA | 9.59 | |||||
EV-to-Revenue | 0.97 | |||||
EV-to-Forward-Revenue | 0.88 | |||||
EV-to-FCF | 35.27 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 0.46 | |||||
Price-to-Median-PS-Value | 1.22 | |||||
Earnings Yield (Greenblatt) % | 7.01 | |||||
FCF Yield % | 7.43 | |||||
Forward Rate of Return (Yacktman) % | -3.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Select Medical Holdings Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4,763.504 | ||
| EPS (TTM) (€) | 0.919 | ||
| Beta | 0.1013 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.08 | ||
| Volatility % | 27.68 | ||
| 14-Day RSI | 60.96 | ||
| 14-Day ATR (€) | 0.098853 | ||
| 20-Day SMA (€) | 14.265 | ||
| 12-1 Month Momentum % | 11.2 | ||
| 52-Week Range (€) | 9.9 - 14.4 | ||
| Shares Outstanding (Mil) | 123.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Select Medical Holdings Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Select Medical Holdings Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-19 09:00 | In 151 days | ||
| Annual report for 2026 | 2027-02-19 | In 150 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-19 | In 150 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-30 09:00 | In 39 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 38 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 09:00 | 14.40 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-31 | 14.40 (+0.00%) | ||
| USD 0.062500 Cash Dividend | 2026-05-14 | 13.70 (-1.44%) | ||
| First quarter earnings conference call for 2026 | 2026-05-01 09:00 | 13.80 (-0.72%) | ||
| First quarter earnings results for 2026 | 2026-05-01 | 13.80 (-0.72%) |
Show
Entries
Select Medical Holdings Corp Frequently Asked Questions
What is Select Medical Holdings Corp(FRA:S24)'s stock price today?
The current price of FRA:S24 is €14.40. The 52 week high of FRA:S24 is €14.40 and 52 week low is €9.90.
When is next earnings date of Select Medical Holdings Corp(FRA:S24)?
The next earnings date of Select Medical Holdings Corp(FRA:S24) is 2026-10-30 Est..
Does Select Medical Holdings Corp(FRA:S24) pay dividends? If so, how much?
The Dividend Yield %  of Select Medical Holdings Corp(FRA:S24) is 1.5% (As of Today), Highest Dividend Payout Ratio of Select Medical Holdings Corp(FRA:S24) was 0.9. The lowest was 0.13. And the median was 0.41. The  Forward Dividend Yield % of Select Medical Holdings Corp(FRA:S24) is 1.49%. For more information regarding to dividend, please check our Dividend Page.